The effect of hormonal alterations on bone turnover markers in women with surgical and natural menopause

Yıl 2008, Cilt: 39 Sayı: 4, 161 - 165, 01.05.2008

Berna Haliloğlu Fehime Benli Aksungur Aygen Çelik Erdin İlter Figen Temelli Akın Ümit Özekici

Öz

Objective: In surgical and natural menopause, bone turnover alterations due to estrogen deficiency result in osteoporosis. In the present study, the effect of hormonal alterations on bone turnover markers in women with surgical and natural menopause was planned. Material and Methods: Sixty women with natural menopause and 60 women with surgical menopause applied to menopause clinic of Maltepe Medical Faculty were included study. Serum follicle stimulating hormone (FSH), estradiol (E2), dehydroepiandrosterone sulphate (DHEAS), cortisole, bone-spesific alkaline phosphatase (BAP), paratyroid hormone (PTH), collagen C-telopeptite (CTX) and calcium (Ca) levels were measured. Results: Serum PTH, CTX, E2 and DHEAS levels were higher in women with natural menopause. In women with surgical menopause, serum BAP, cortisole and Ca levels were higher than those with natural menopause. However, these differences were not statistically significant. Serum BAP levels were positively correlated with age, serum cortisole and CTX (r=0.308p=0.004; r=0.301 p=0.023; r=0.302p=0.005; respectively). Serum CTX levels were positively correlated with serum PTH levels (r=0.271 p=0. Oil). While serum PTH levels were positively correlated with age and years since menopause (r=0.381 p=00001; r=0.318p=0.015; respectively), it was negatively correlated with BMI (r=-2.33 p=0.032). Serum DHEAS levels were negatively correlated with age and years since menopause (r=-0.220 p=0.041; r—-0.291 p=0.030; respectively). Conclusion: We concluded that, except estrogen deficiency, there may be various factors for osteoporosis in cases with natural and surgical menopause.

Anahtar Kelimeler

Menopause, Charybdotoxin, Parathyroid Hormone, Follicle Stimulating Hormone, Estradiol, Alkaline Phosphatase

Doğal ve cerrahi menopoz olgularındaki hormonal değişimin kemik döngüsüne etkisi

Öz

Amaç: Hem doğal hem de cerrahi menopozda özellikle östrojen eksikliğine bağlı olarak kemik döngüsü değişmekte ve osteoporoz olasılığı artmaktadır. Bu çalışmada doğal ve cerrahi menopozda meydana gelen hormonal değişikliklerin kemik döngüsü belirteçleri üzerine etkilerinin araştırılması planlandı. Materyal ve Metod: Maltepe Üniversitesi Tıp Fakültesi Menopoz Polikliniği 'ne başvuran 60 doğal menopozlu ve 60 cerrahi menopozlu hasta çalışmaya alındı. Serum folikül stimulan hormon (FSH), östradiol (E2), dehidroepiandrosteron sülfat (DHEAS), kortizol, kemik-spesifık alkalen fosfataz (BAP), paratiroid hormon (PTH), kollajen C-telopeptit (CTX) ve kalsiyum (Ca) düzeyleri ölçüldü. Bulgular: Doğal menopozlu kadınlarda serum PTH, CTX, E2 ve DHEAS seviyeleri; cerrahi menopozlu kadınlarda ise serum BAP, kortizol ve Ca seviyeleri artmış olarak bulunmasına rağmen, her iki grup arasında anlamlı farklılık tespit edilmedi. Serum BAP seviyesinin yaş, serum kortizol ve CTX parametreleri ile pozitif kor ele olduğu gözlendi (sırasıyla r=0.308p=0.004; r=0.301 p=0.023; r=0.302p=0.005). Serum CTXseviyeleri PTH ile pozitif korele bulundu (r=0.271 p=0.011). Serum PTH seviyelerinin ayrıca yaş ve menopoz süresi ile pozitif korele olduğu saptanırken (sırasıyla r=0.381 p=00001; r=0.318 p=0.015), BMI ile PTH arasında ise negatif korelasyon bulundu (r=-2.33 p=0.032). Serum DHEAS seviyeleri ise yaş ve menopoz süresi ile negatif korele bulundu (sırasıyla r=-0.220p=0.041; r=-0.291 p=0.030). Sonuç: Doğal ve cerrahi menopozda oluşan osteoporoz riskinin altında östrojen eksikliği dışında pek çok faktörün olduğunu düşünmekteyiz.

Anahtar Kelimeler

Menopoz, Karibdotoksin, Paratiroid hormonu, Folikül uyarıcı hormon, Östradiol, Alkalin fosfataz

Kaynakça

• 1.Richelson LS, Wahner HW, Melton LJ, Riggs BL. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N EnglJ Med 1984; 311:1273-5
• 2.Ertunç D, Tok E, Gülhan S, Yazıcı G, Kaplanoğlu M, Aban M et al. Ooferektominin postmenopozal kemik mineral yoğunluğu üzerine etkisi. Jinekoloji ve Obstetrik Bülteni 2005; 12:59-64
• 3.Berek JS, Adashi EY, Hillard PJA (Çeviri Editörü: Doç.Dr. Ahmet Erk) Novak Jinekoloji. Nobel Tıp Kitabevleri. 2004;29:1109-1139
• 4.Lambrinoudaki I, Christodoulakos G, Avarantinos L, Antoniou A, Rizos D et al. Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women. JBone Miner Metab 2006; 24:65-71
• 5.Kass-WoljfJH. Calcium in women: healthy bones and much more. J Obstet Gynecol Neonatal Nurs 2004; 33:21-33
• 6.Braunstein GD. Androgen insufficiency in women: summary of critical issues. Fertil Steril 2002; 77:94-99
• 7.Burger HG, Dudley EC, Hopper JL, Groome N, Guthrie JR, Gree A, Dennestein L. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999; 84:4025-4030
• 8.Yoshimura N, Kasamatsu T, Sakata K, Hashimoto T, Cooper C. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji study. J Bone Miner Metab 2002; 20:303-310
• 9.Garcia-Perez MA, Moreno-Mercer J, Tarin JJ, Cano A. Bone turnover markers and PTH levels in surgical versus natural menopause. Calcif Tissue Int 2004; 74:143-149
• 10.Acar B, Uslu T, Topuz A, Osma E, Ercal T et al. Relation between bone mineral content and clinical, hormonal and biochemical parameters in postmenopausal women. Arch Gynecol Obstet 1998;261:121-128
• 11.Haffner SM, Katz MS, Dunn JF. Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Inter Jour Obs 1991; 15:471-478
• 12.Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biomedical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELYstudy. JBone Miner Res 2000; 15:1526-1536
• 13.Szathmari M, Szucs J, Feher T, Hollo I. Dehydroepiandrosterone sulphate and bone mineral density. Osteoporos Int 1994; 4:84-88
• 14.Watson RR, Huls A, Araghinikuam M, Chung S. Dehydroepiandrosterone and diseases of aging. Drugs Aging 1996; 9:274-291
• 15.Eastell R, Yergey AL, Vieira NE, Cedel SL, Kumar R, Riggs BL. Interrelationship among vitamin D metabolism, free calcium absorption, parathyroid function, and age in women: evidence of a age-related intestinal resistance to 1,25-dihydroxyvitamin D action. JBone Miner Res 1991; 6:125-132
• 16.CantatoreFP, Loverro G, IngrossoA, Lacanna R, Sassanelli E, Selvaggi L et al. Effect of estrogen replacement on bone metabolism and cytokins in surgical menopause. Clin Rheumatol 1995; 14:157-160
• 17.Mazzuoli G, Minisola S, Bianchi G, Pacitti MT, Rosso R, Romagnoli E et al. The effect of oophorectomy on skeletal metabolism. J Steroid Biochem Mol Biol 1990; 37:457-459
• 18.Baca E A, Ulibarri VA, Scariano JK, Ujah I, Bassi A, Rabasa Al et al. Increased serum levels of N-telopeptides(NTX) of bone collagen in postmenopoausal Nigeria women. Calcif Tissue Int 1999; 65:125-128
• 19.Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C et ah. Markers of bone resorption predict hip fracture in elderly women: The EPIDOSprospective study. J Bone Miner Res 1996; 11:1531-1538
• 20.Desai MP, Bhanuprakash KV, Khatkhatay MI, Donde UM. Age-related changes in bone turnover markers and ovarian hormones in premenopausal and postmenopausal Indian women. J Clin Lab Aral 2007; 21:55-60
• 21.Avbersek-Luznik I, Gmeiner Stopar T, Marc J. Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation. Clin Chem Lab Med 2007; 45:1014-1018
• 22.Peris P, Alvarez L, Monegal A, Guanabens N, Duran M, Pons F et ah Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy. Bone 1999; 25:349-353.